Patanase
NDC Package 58118-9924-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Patanase is olopatadine is used to relieve symptoms of seasonal allergies that occur in the nose, such as runny/itchy/stuffy nose, sneezing, and post-nasal drip. Marketed by Clinical Solutions Wholesale, this product is identified by NDC 58118-9924 and is authorized under FDA application NDA021861.

Identification & Billing

NDC Package Code
58118-9924-3
Package Description
240 SPRAY, METERED in 1 BOTTLE
Product Code
58118-9924
11-Digit Billing Format
58118992403

Clinical Specifications

Proprietary Name
Patanase
Dosage Form
-
Usage Information
Olopatadine is used to relieve symptoms of seasonal allergies that occur in the nose, such as runny/itchy/stuffy nose, sneezing, and post-nasal drip. This medication is an antihistamine. It works by blocking certain natural substances called histamines that are responsible for allergic symptoms. Do not use this medication in children younger than 2 years unless specifically directed by the doctor. To decrease the risk for serious side effects, carefully follow all of the doctor's dosage directions. Do not give other cough and cold medication that might contain the same or similar ingredients (see also Drug Interactions section). Ask your doctor or pharmacist about other ways to relieve cough and cold symptoms (such as saline nose drops/spray, using a humidifier or infant nasal suction bulb).

Regulatory & Marketing

Labeler Name
Clinical Solutions Wholesale
FDA Application #
NDA021861
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-28-2008
End Marketing Date
06-26-2017
Listing Expiration
06-26-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58118-9924-3 identifies a specific commercial package of 240 spray, metered in 1 bottle of Patanase, labeled by Clinical Solutions Wholesale. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Clinical Solutions Wholesale on April 28, 2008. The current certification is valid through June 26, 2017.

What are the primary indications for this medication?

Olopatadine is used to relieve symptoms of seasonal allergies that occur in the nose, such as runny/itchy/stuffy nose, sneezing, and post-nasal drip. This medication is an antihistamine. It works by blocking certain natural substances called histamines that are responsible for allergic symptoms. Do not use this medication in children younger than 2 years unless specifically directed by the doctor. To decrease the risk for serious side effects, carefully follow all of the doctor's dosage directions. Do not give other cough and cold medication that might contain the same or similar ingredients (see also Drug Interactions section). Ask your doctor or pharmacist about other ways to relieve cough and cold symptoms (such as saline nose drops/spray, using a humidifier or infant nasal suction bulb).

How is this Clinical Solutions Wholesale product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58118992403. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
58118-9924-3
11-Digit CMS (5-4-2)
58118-9924-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.